Australian Clinical Labs Ltd ACL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$2.82
- Day Range
- A$2.83–2.83
- 52-Week Range
- A$1.83–3.03
- Bid/Ask
- A$2.80 / A$2.82
- Shares Outstanding
- 186.52M
- Market Cap
- A$527.85M
- Volume/Avg
- 1 / 671,929
Key Statistics
- Price/Earnings (Normalized)
- 12.65
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- 4.61%
- Dividend Yield (Forward)
- 4.61%
- Dividend Payment Schedule
- Mar, Sep
- Total Yield
- 9.01%
Company Profile
Australian Clinical Labs is Australia's third-largest private pathology service provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.clinicallabs.com.au
Valuation
|
Metric
|
ACL
|
|---|---|
Price/Earnings (Normalized) | 12.65 |
Price/Book Value | 3.52 |
Price/Sales | 0.74 |
Price/Cash Flow | 3.32 |
Price/Earnings
ACL
Financial Strength
|
Metric
|
ACL
|
|---|---|
Quick Ratio | 0.50 |
Current Ratio | 0.59 |
Interest Coverage | 3.33 |
Quick Ratio
ACL
Profitability
|
Metric
|
ACL
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ACL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|>#b?^LL! | LOCK|Xt | $243B | |||
| Danaher Corp
DHR
| LOCK|N$^w^Xt^ | LOCK|!n! | $152B | |||
| Agilent Technologies Inc
A
| LOCK|d%@lF<&% | LOCK|x# | $48B | |||
| Waters Corp
WAT
| LOCK|kpPbLJ | LOCK|GYf | $43B | |||
| IQVIA Holdings Inc
IQV
| LOCK|mW@W!MT | LOCK|JC@M | $43B | |||
| Illumina Inc
ILMN
| LOCK|v#%CpL | LOCK|$!d@ | $41B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|gC!gPv# | LOCK|@!^ | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|C#DylTQ | LOCK|&!?#s | $31B | |||
| Labcorp Holdings Inc
LH
| LOCK|%%wYN&^Y | LOCK|$gVb | $25B | |||
| Quest Diagnostics Inc
DGX
| LOCK|LY?HbD | LOCK|^>&Bv | $25B |
United States